United States Central Venous Catheters Market Outlook to 2023

Publisher Name :
Date: 01-Aug-2017
No. of pages: 68

United States Central Venous Catheters Market Outlook to 2023

Summary

GlobalData's new report, "United States Central Venous Catheters Market Outlook to 2023", provides key market data on the United States Central Venous Catheters market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Antimicrobial Central Venous Catheters, Non Antimicrobial Central Venous Catheters and PICC (Peripherally Inserted Central Catheter) Lines.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Central Venous Catheters market segments - Antimicrobial Central Venous Catheters, Non Antimicrobial Central Venous Catheters and PICC (Peripherally Inserted Central Catheter) Lines.

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

- 2016 company shares and distribution shares data for each of the market segments.

- Global corporate-level profiles of key companies operating within the United States Central Venous Catheters market.

- Key players covered include Teleflex Inc, C. R. Bard Inc, Edwards Lifesciences Corp and B. Braun Melsungen AG.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

United States Central Venous Catheters Market Outlook to 2023

Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Central Venous Catheters Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Central Venous Catheters Market, United States 7
3.1 Central Venous Catheters Market, United States, Revenue ($m), 2009-2016 7
3.2 Central Venous Catheters Market, United States, Revenue ($m), 2016-2023 9
3.3 Central Venous Catheters Market, United States, Volume (Units), 2009-2016 11
3.4 Central Venous Catheters Market, United States, Volume (Units), 2016-2023 13
3.5 Central Venous Catheters Market, United States, Average Price ($), 2009-2023 15
3.6 Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), 2015-2016 16
3.7 Central Venous Catheters Market, United States, Company Share by Revenue ($m), 2016 17
4 Overview of Key Companies in United States, Central Venous Catheters Market 19
4.1 Teleflex Inc 19
4.1.1 Company Overview 19
4.2 C. R. Bard Inc 19
4.2.1 Company Overview 19
4.3 Edwards Lifesciences Corp 19
4.3.1 Company Overview 19
4.4 B. Braun Melsungen AG 20
4.4.1 Company Overview 20
4.5 Smiths Medical 20
4.5.1 Company Overview 20
5 Central Venous Catheters Market Pipeline Products 21
6 Financial Deals Landscape 22
6.1 Debt Offerings 22
6.1.1 PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 22
6.1.2 Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 23
6.1.3 Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 24
6.1.4 Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 25
6.1.5 Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 26
6.1.6 Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 27
6.1.7 Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 28
6.1.8 Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 29
6.1.9 Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019 30
6.1.10 Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 31
6.1.11 Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 33
6.2 Equity Offerings 35
6.2.1 Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 35
6.2.2 Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 37
6.2.3 PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 39
6.2.4 PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 40
6.2.5 PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 41
6.2.6 PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 42
7 Recent Developments 43
7.1 Corporate Communications 43
7.1.1 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 43
7.1.2 Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer 43
7.1.3 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 44
7.1.4 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 44
7.2 Financial Announcements 45
7.2.1 May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 45
7.2.2 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 45
7.2.3 May 04, 2017: Teleflex Reports First Quarter 2017 Results 46
7.2.4 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 47
7.2.5 Apr 03, 2017: Retractable Technologies Reports Results for the Year 2016 49
7.2.6 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 49
7.2.7 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 50
7.2.8 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 51
7.2.9 Nov 14, 2016: Retractable Technologies Reports Results as of September 30, 2016 52
7.2.10 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 53
7.2.11 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 54
7.2.12 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 55
7.2.13 Aug 16, 2016: PAVmed Announces Second Quarter 2016 Financial Results and Provides Business Update 57
7.2.14 Aug 16, 2016: Retractable Technologies Reports Results as of June 30, 2016 58
7.2.15 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 59
7.2.16 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 59
7.2.17 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 61
7.3 Government and Public Interest 62
7.3.1 Jun 06, 2017: BD Releases 2016 Sustainability Report 62
7.3.2 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 62
7.4 Legal And Regulatory 63
7.4.1 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 63
7.4.2 Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit's Opinion 63
8 Appendix 64
8.1 Research Methodology 65
8.1.1 Coverage 65
8.1.2 Secondary Research 65
8.1.3 Primary Research 66
8.1.4 Company Share Analysis 66
8.1.5 Distribution Share Analysis 66
8.1.6 Benchmarking 67
8.2 GlobalData Consulting 67
8.3 Contact Us 68
8.4 Disclaimer 68

1.1 List of Tables
Table 1: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 8
Table 2: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 10
Table 3: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016 12
Table 4: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023 14
Table 5: Central Venous Catheters Market, United States, Average Price ($), Historic, 2009-2016 15
Table 6: Central Venous Catheters Market, United States, Average Price ($), Forecast, 2016-2023 15
Table 7: Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 16
Table 8: Central Venous Catheters Market, United States, Company Share by Revenue ($m), USD Constant, 2016 18
Table 9: Central Venous Catheters Market Pipeline Products 21
Table 10: PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 22
Table 11: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 23
Table 12: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 24
Table 13: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 25
Table 14: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 26
Table 15: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 27
Table 16: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 28
Table 17: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 29
Table 18: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019 30
Table 19: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 31
Table 20: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 33
Table 21: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 35
Table 22: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 37
Table 23: PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 39
Table 24: PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 40
Table 25: PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 41
Table 26: PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 42

1.2 List of Figures
Figure 1: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 7
Figure 2: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 9
Figure 3: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016 11
Figure 4: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023 13
Figure 5: Central Venous Catheters Market, United States, Company Share (%) 2016 17
  • United States Medical Nebulizer Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 113
    In this report, the United States Medical Nebulizer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate o......
  • Global Drug Device Combination Products Market Size, Status and Forecast 2022
    Published: 11-Dec-2017        Price: US 3300 Onwards        Pages: 96
    This report studies the global Drug Device Combination Products market, analyzes and researches the Drug Device Combination Products development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Medtronic - Boston Scientific Corporation - Stryker Corporation - Ethicon Inc - C.R. Bard Inc. - Medline Industries Inc. - Mylan Inc. - Terumo Corporatio......
  • Global Medical Nebulizer Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the global Medical Nebulizer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Medical Nebulizer for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • United States Ultrasonic Nebulizer Market Report 2017
    Published: 05-Dec-2017        Price: US 3800 Onwards        Pages: 100
    In this report, the United States Ultrasonic Nebulizer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rat......
  • Global Inhalation Therapy Nebulizer Market Data Survey Report 2025
    Published: 30-Nov-2017        Price: US 1500 Onwards        Pages: 77
    Summary A nebulizer changes medication from a liquid to a mist so that it can be more easily inhaled into the lungs. Nebulizers are particularly effective in delivering asthma medications to infants and small children and to anyone who has difficulty using an asthma inhaler. The global Inhalation Therapy Nebulizer market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and for......
  • Global Ultrasonic Nebulizer Sales Market Report 2017
    Published: 30-Nov-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Ultrasonic Nebulizer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ultrasonic Nebulizer for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - ......
  • United States Metered Dose Inhalers Market Report 2017
    Published: 29-Nov-2017        Price: US 3800 Onwards        Pages: 114
    In this report, the United States Metered Dose Inhalers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ra......
  • Global and Regional Inhalation Therapy Nebulizer Market Research Report 2017
    Published: 24-Nov-2017        Price: US 3500 Onwards        Pages: 143
    Summary A nebulizer changes medication from a liquid to a mist so that it can be more easily inhaled into the lungs. Nebulizers are particularly effective in delivering asthma medications to infants and small children and to anyone who has difficulty using an asthma inhaler. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type......
  • Global Metered Dose Inhalers Sales Market Report 2017
    Published: 24-Nov-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the global Metered Dose Inhalers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Metered Dose Inhalers for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs